BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4
231 results:

  • 1. EZH2/G9a interact to mediate drug resistance in non-small-cell lung cancer by regulating the smad4/ERK/c-Myc signaling axis.
    Zhang Q; Shi Y; Liu S; Yang W; Chen H; Guo N; Sun W; Zhao Y; Ren Y; Ren Y; Jia L; Yang J; Yun Y; Chen G; Wang L; Wu C
    Cell Rep; 2024 Feb; 43(2):113714. PubMed ID: 38306271
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Transformation to small cell lung cancer is irrespective of EGFR and accelerated by smad4-mediated ASCL1 transcription independently of RB1 in non-small cell lung cancer.
    Ding X; Shi MX; Liu D; Cao JX; Zhang KX; Zhang RD; Zhang LP; Ai KX; Su B; Zhang J
    Cell Commun Signal; 2024 Jan; 22(1):45. PubMed ID: 38233864
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical-Molecular characteristics and Post-Translational modifications of colorectal cancer in north China: Implications for future targeted therapies.
    Chi Y; Yuan H; Fan Q; Wang Z; Niu Z; Yu J; Yuan D
    Gene; 2024 Mar; 899():148134. PubMed ID: 38185290
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diagnostic Utility of Next-Generation Sequencing in Circulating Free DNA and a Comparison With Matched Tissue in Gallbladder Carcinoma.
    Mishra S; Srivastava P; Pandey A; Shukla S; Agarwal A; Husain N
    Lab Invest; 2024 Feb; 104(2):100301. PubMed ID: 38092180
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy.
    Hua YC; Gao DZ; Wang KY; Ding XS; Xu WR; Li YB; Shi WW; Sun SB; Li XY
    Thorac Cancer; 2023 Nov; 14(31):3133-3139. PubMed ID: 37718465
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. SUMOylation of smad4 by PIAS1 in Conjunction with Vimentin Upregulation Promotes Migration Potential in Non-Small Cell lung cancer.
    Wu C; Zhu X; Dai Q; Chu Z; Yang S; Dong Z
    Front Biosci (Landmark Ed); 2023 Aug; 28(8):192. PubMed ID: 37664931
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Inducible nitric oxide synthase (iNOS)-activated Cxcr2 signaling in myeloid cells promotes TGFβ-dependent squamous cell carcinoma lung metastasis.
    Li X; Ke Y; Hernandez AL; Yu J; Bian L; Hall SC; Nolan K; Wang JH; Young CD; Wang XJ
    Cancer Lett; 2023 Aug; 570():216330. PubMed ID: 37524225
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinicopathological and prognostic significance of smad4 in non-small cell lung cancer: A meta-analysis and database validation.
    Li Z; Huang Y; Zhou R; Li Z; Yan Q
    Medicine (Baltimore); 2023 Jul; 102(29):e34312. PubMed ID: 37478236
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. 5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-smad4 signaling.
    Singh DK; Carcamo S; Farias EF; Hasson D; Zheng W; Sun D; Huang X; Cheung J; Nobre AR; Kale N; Sosa MS; Bernstein E; Aguirre-Ghiso JA
    Cell Rep; 2023 Jun; 42(6):112560. PubMed ID: 37267946
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Socioeconomic disparities in immunotherapy use among advanced-stage non-small cell lung cancer patients: analysis of the National cancer Database.
    Gupta A; Omeogu C; Islam JY; Joshi A; Zhang D; Braithwaite D; Karanth SD; Tailor TD; Clarke JM; Akinyemiju T
    Sci Rep; 2023 May; 13(1):8190. PubMed ID: 37210410
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genomic alterations of cerebrospinal fluid cell-free DNA in leptomeningeal metastases of gastric cancer.
    Chen X; Bai K; Zhang Y; Xu Y; Huo Y; Wang S; Zou Y; Qi X; Guo R; Ou Q; Liu D; Yin S; Chen S; Bu H
    J Transl Med; 2023 May; 21(1):296. PubMed ID: 37131253
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing.
    Machida H; Matsuo K; Tanaka M; Kitatani K; Takase A; Yokoyama K; Kajiwara H; Yasaka M; Ikeda M; Yoshida H; Hirasawa T; Mikami M
    Gynecol Oncol; 2023 Apr; 171():59-66. PubMed ID: 36804622
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Loss of function smad4 nonstop mutations in human cancer.
    Bauer AH; Basta DW; Hornick JL; Dong F
    Histopathology; 2023 Jun; 82(7):1098-1104. PubMed ID: 36740808
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Cell-Fate Reprogramming Strategy Reverses Epithelial-to-Mesenchymal Transition of lung cancer Cells While Avoiding Hybrid States.
    Kim N; Hwang CY; Kim T; Kim H; Cho KH
    Cancer Res; 2023 Mar; 83(6):956-970. PubMed ID: 36710400
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. ATOH8 binds SMAD3 to induce cellular senescence and prevent Ras-driven malignant transformation.
    Liu X; Li X; Wang S; Liu Q; Feng X; Wang W; Huang Z; Huang Y; Wu J; Cai M; Cai X; Xu X; Cai J; Li M
    Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2208927120. PubMed ID: 36626550
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Adult Pancreatoblastoma: Report of 3 new Cases With Genetic Diversity and Autopsy Findings.
    Machado I; López-Guerrero JA; Fernandez A; López R; García Casado Z; Ferrandez A; Llombart-Bosch A; Charville GW
    Int J Surg Pathol; 2023 Aug; 31(5):896-906. PubMed ID: 36573045
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Changes of gene expression in peripheral blood mononuclear cells of lung cancer patients with or without anorexia.
    Molfino A; Ambrosani F; Tambaro F; Belli R; Imbimbo G; Udali S; Moruzzi S; Pattini P; Ramaccini C; Castagna A; Muscaritoli M; Friso S
    Clin Nutr; 2023 Jan; 42(1):9-17. PubMed ID: 36473427
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification of nine mutant genes and establishment of three prediction models of organ tropism metastases of non-small cell lung cancer.
    Chen S; Huang W; Liu Z; Jin M; Li J; Meng L; Li T; Diao Y; Gao H; Hong C; Zheng J; Li F; Zhang Y; Bi D; Teng L; Li X
    Cancer Med; 2023 Feb; 12(3):3089-3100. PubMed ID: 36161776
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer.
    Wang C; Zhang Z; Sun Y; Wang S; Wu M; Ou Q; Xu Y; Chen Z; Shao Y; Liu H; Hou P
    J Transl Med; 2022 Sep; 20(1):390. PubMed ID: 36059009
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Detection of Potential Mutated Genes Associated with Common Immunotherapy Biomarkers in Non-Small-Cell lung cancer Patients.
    Cao L; Cao Z; Liu H; Liang N; Bing Z; Tian C; Li S
    Curr Oncol; 2022 Aug; 29(8):5715-5730. PubMed ID: 36005189
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.